Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin

NCT00630877 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

276

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: Niacin extended-release (NER)
DRUG: Niacin extended-release (NER) placebo
DRUG: Aspirin (ASA)
DRUG: Aspirin (ASA) placebo

Sponsor

Abbott